LEUKEMIA, B-CELL
Clinical trials for LEUKEMIA, B-CELL explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA, B-CELL trials appear
Sign up with your email to follow new studies for LEUKEMIA, B-CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug pirtobrutinib takes on standard therapy in major CLL trial
Disease control Recruiting nowThis phase 3 study compares a new drug, pirtobrutinib, to the standard drug ibrutinib in people with chronic lymphocytic leukemia or small lymphocytic lymphoma. About 662 participants, who may or may not have had prior treatment, will receive one of the two drugs. The goal is to …
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE3 • Sponsor: Loxo Oncology, Inc. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New hope for tough blood cancers: first human trial of MGD024 begins
Disease control Recruiting nowThis early-stage study tests a new drug called MGD024 in about 130 adults with certain blood cancers (like leukemia or lymphoma) that did not get better with standard treatments or came back. The main goal is to find a safe dose and understand side effects. Participants receive t…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 11, 2026 20:54 UTC
-
Triple-targeting CAR-T cells aim to outsmart stubborn leukemia
Disease control Recruiting nowThis study tests a new treatment for children and young adults (ages 1-25) with B-cell acute lymphoblastic leukemia (ALL) that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells (T cells) that are modified in the lab to recognize…
Matched conditions: LEUKEMIA, B-CELL
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC